Search Results for 'Oncol-Cancer'

Oncol-Cancer published presentations and documents on DocSlides.

SIRT Steve Falk Consultant Clinical Oncologist
SIRT Steve Falk Consultant Clinical Oncologist
by desha
dd. /mm/. yyyy. Selective Internal Radiation Thera...
LeadingEdgeItsaCullenTaniguchiandAnirbanMaitraDepartmentsofRadiationO
LeadingEdgeItsaCullenTaniguchiandAnirbanMaitraDepartmentsofRadiationO
by roberts
,June4,20152015ElsevierInc. surprisingthatpositive...
Diffuse Intrinsic Pontine Glioma
Diffuse Intrinsic Pontine Glioma
by natalie
ARRO Case: Nicholas DeNunzio, MD, PhD (PGY - 3) F...
ContentslistsavailableatCriticalReviewsinOncologyHematologyjournalhom
ContentslistsavailableatCriticalReviewsinOncologyHematologyjournalhom
by isla
CervicalcancerpatternsofcareinItalyAradiationoncol...
METASTASES HEPATIQUES CRC :point de vue de l’ oncologue
METASTASES HEPATIQUES CRC :point de vue de l’ oncologue
by jiggyhuman
F DESSEIGNE TANGER 27 04 2018. Phase III First-Lin...
High Grade  Gliomas :  Case Presentation and Summary of Evidence for Radiation Therapy Management
High Grade Gliomas : Case Presentation and Summary of Evidence for Radiation Therapy Management
by stylerson
Jonathan Klein. PGY3, . Radiation . Oncology. Univ...
GIスライドデッキ2018
GIスライドデッキ2018
by crandone
以下の会議で発表された特定の抄録...
Tratamento sistêmico em Melanoma
Tratamento sistêmico em Melanoma
by blondiental
Luiz Gustavo . Sueth. . Berriel. Oncologista Clí...
Josep Tabernero,  MD PhD Medical  Oncology Department Vall
Josep Tabernero, MD PhD Medical Oncology Department Vall
by test
Josep Tabernero, MD PhD Medical Oncology Depa...
High Grade  Gliomas :  Case Presentation and Summary of Evidence for Radiation Therapy Management
High Grade Gliomas : Case Presentation and Summary of Evidence for Radiation Therapy Management
by myesha-ticknor
Jonathan Klein. PGY3, . Radiation . Oncology. Uni...
Emerging Concepts in the Management of Skin
Emerging Concepts in the Management of Skin
by pasty-toler
Cancer. Perspectives From the 2015 Oncology . Mee...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by tatiana-dople
Contemporary Treatment Strategies and Optimal Seq...
Is Sentinel Lymph Node Biopsy Enough for Axillary
Is Sentinel Lymph Node Biopsy Enough for Axillary
by conchita-marotz
Macrometastasis. ? . Merdan . Fayda. , MD, . Asso...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by alexa-scheidler
Contemporary Treatment Strategies and Optimal Seq...
Is Sentinel Lymph Node Biopsy Enough for Axillary
Is Sentinel Lymph Node Biopsy Enough for Axillary
by tatyana-admore
Macrometastasis. ? . Merdan . Fayda. , MD, . Asso...
Recent developments in the treatment of DLBCL
Recent developments in the treatment of DLBCL
by payton
Prof. Georg Lenz, MD. Department of Haematology, O...
CLINICAL EXPERIENCE OF NSCLC in RSDM
CLINICAL EXPERIENCE OF NSCLC in RSDM
by sophia
Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...
Translating the biology of diffuse large B-cell lymphoma into treatment
Translating the biology of diffuse large B-cell lymphoma into treatment
by callie
Prof. . Alexey V. Danilov, MD, PhD,. 1. Dr. Massi...
GI CONNECT  MEETING SUMMARY
GI CONNECT MEETING SUMMARY
by hanah
upper . gi. cancer HIGHLIGHTS . FROM ESMO 2022. D...
Big data for health Prof. Philippe Lambin
Big data for health Prof. Philippe Lambin
by harper
U.H. Maastricht. Third pillars of CERN: “Storage...
IntensityModulated Radiation Therapy 10 IntensityModulated Radiation
IntensityModulated Radiation Therapy 10 IntensityModulated Radiation
by arya
D. A. Low, , W. Lu, , C. A. Perez, MDDepartment of...
ARRO Case Low Grade
ARRO Case Low Grade
by anderson
Glioma (LGG) Stephanie Rice, BS (MSIV), Abigail T....
Page 2 of 33Liand Song J Hematol Oncol           2021 1456
Page 2 of 33Liand Song J Hematol Oncol 2021 1456
by adia
normal stem/progenitor cells in the bone marrow an...
0J0H0Z0L030Y0L0W0V0Y0
0J0H0Z0L030Y0L0W0V0Y0
by lucy
Hematol Oncol Stem Cell Ther 1(2) April 2008 h...
ML  for   personalised
ML for personalised
by CuteKitten
radiotherapy. Dr. Alex Zwanenburg. 06.12.2021. Why...
Tanya M. Wildes, MD,  MSCI
Tanya M. Wildes, MD, MSCI
by HoneyBun
June 28, 2018. Management of hematologic malignanc...
Treatment-related Adverse Effects in MDS:
Treatment-related Adverse Effects in MDS:
by emmy
Managing Them Before They Derail Therapy. Amy E. D...
Decision Making in Pediatric Palliative Care
Decision Making in Pediatric Palliative Care
by heavin
Scott Maurer, MD. Assistant Professor of Pediatric...
Case Study:  A  P atient
Case Study: A P atient
by faith
with PV and . Debilitating . S. ymptoms on HU. Srd...
Mechanisms of ALK Resistance & Implications for Treatment
Mechanisms of ALK Resistance & Implications for Treatment
by evans
Robert C. Doebele, MD, PhD. Associate Professor, ....
Immuno-Oncology Adverse Event Management
Immuno-Oncology Adverse Event Management
by everly
Why is it different? . Why is it important?. Dr Av...
ContentslistsavailableatSeminarsinCancerBiologyjournalhomepagewwwelsev
ContentslistsavailableatSeminarsinCancerBiologyjournalhomepagewwwelsev
by audrey
DecodingandtargetingthemolecularbasisofMACC1-drive...
ContentslistsavailableatEuropeanJournalofOncologyNursingjournalhomepag
ContentslistsavailableatEuropeanJournalofOncologyNursingjournalhomepag
by eleanor
ExerciseApositivefeatureonfunctioningindailylifedu...
DRA. CRUZ MORALES GEORGINA R1GO
DRA. CRUZ MORALES GEORGINA R1GO
by bubbleba
TUMORES DEL ESTROMA GONADAL. Temario. Introducció...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
by sherrill-nordquist
The Coming Paradigm Shift. Faculty. Suresh S. Ram...